Sittner & Nelson’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
44,726
-1,131
| -2% | -$27.4K | 0.44% | 45 |
|
|
2025
Q1 | $1.16M | Buy |
45,857
+2,832
| +7% | +$71.8K | 0.5% | 36 |
|
|
2024
Q4 | $1.14M | Sell |
43,025
-11,308
| -21% | -$300K | 0.49% | 38 |
|
|
2024
Q3 | $1.57M | Sell |
54,333
-4,097
| -7% | -$119K | 0.7% | 28 |
|
|
2024
Q2 | $1.63M | Sell |
58,430
-5,742
| -9% | -$161K | 0.81% | 27 |
|
|
2024
Q1 | $1.78M | Buy |
64,172
+1,837
| +3% | +$51K | 0.9% | 26 |
|
|
2023
Q4 | $1.79M | Buy |
62,335
+4,567
| +8% | +$131K | 0.96% | 24 |
|
|
2023
Q3 | $1.92M | Buy |
57,768
+9,049
| +19% | +$300K | 1.1% | 23 |
|
|
2023
Q2 | $1.79M | Sell |
48,719
-5,800
| -11% | -$213K | 0.98% | 23 |
|
|
2023
Q1 | $2.22M | Buy |
54,519
+1,397
| +3% | +$57K | 1.28% | 13 |
|
|
2022
Q4 | $2.72M | Buy |
53,122
+758
| +1% | +$38.8K | 1.66% | 10 |
|
|
2022
Q3 | $2.29M | Buy |
52,364
+769
| +1% | +$33.6K | 1.54% | 9 |
|
|
2022
Q2 | $2.71M | Buy |
51,595
+9,844
| +24% | +$516K | 1.77% | 8 |
|
|
2022
Q1 | $2.16M | Buy |
41,751
+781
| +2% | +$40.4K | 1.25% | 18 |
|
|
2021
Q4 | $2.42M | Buy |
40,970
+6,842
| +20% | +$404K | 1.41% | 16 |
|
|
2021
Q3 | $1.47M | Sell |
34,128
-292
| -0.8% | -$12.6K | 0.95% | 27 |
|
|
2021
Q2 | $1.35M | Buy |
34,420
+3,411
| +11% | +$134K | 0.95% | 26 |
|
|
2021
Q1 | $1.12M | Buy |
31,009
+1,816
| +6% | +$65.8K | 0.84% | 32 |
|
|
2020
Q4 | $1.08M | Buy |
+29,193
| New | +$1.08M | 0.96% | 29 |
|